262 related articles for article (PubMed ID: 12571812)
1. The role of pemetrexed in the treatment of colorectal cancer.
Hochster H
Semin Oncol; 2002 Dec; 29(6 Suppl 18):54-6. PubMed ID: 12571812
[TBL] [Abstract][Full Text] [Related]
2. The role of pemetrexed in the treatment of gastrointestinal malignancy.
Hochster HS
Clin Colorectal Cancer; 2004 Sep; 4(3):190-5. PubMed ID: 15377402
[TBL] [Abstract][Full Text] [Related]
3. Pemetrexed in advanced colorectal cancer.
Louvet C; de Gramont A
Oncology (Williston Park); 2004 Nov; 18(13 Suppl 8):56-62. PubMed ID: 15655939
[TBL] [Abstract][Full Text] [Related]
4. Pemetrexed: an active new agent for breast cancer.
O'Shaughnessy JA
Semin Oncol; 2002 Dec; 29(6 Suppl 18):57-62. PubMed ID: 12571813
[TBL] [Abstract][Full Text] [Related]
5. Pemetrexed in bladder, head and neck, and cervical cancers.
Paz-Ares L; Ciruelos E; García-Carbonero R; Castellano D; Lopez-Martín A; Cortés-Funes H
Semin Oncol; 2002 Dec; 29(6 Suppl 18):69-75. PubMed ID: 12571815
[TBL] [Abstract][Full Text] [Related]
6. Future directions in the development of pemetrexed.
Calvert H; Bunn PA
Semin Oncol; 2002 Apr; 29(2 Suppl 5):54-61. PubMed ID: 12023794
[TBL] [Abstract][Full Text] [Related]
7. Pemetrexed: single-agent and combination phase I study overview.
Boyer MJ; Rivory LP; Clarke SJ
Semin Oncol; 2002 Dec; 29(6 Suppl 18):18-23. PubMed ID: 12571806
[TBL] [Abstract][Full Text] [Related]
8. Pemetrexed in pancreatic cancer.
Kindler HL
Semin Oncol; 2002 Dec; 29(6 Suppl 18):49-53. PubMed ID: 12571811
[TBL] [Abstract][Full Text] [Related]
9. Pemetrexed in patients with gastrointestinal carcinoma.
de Gramont A; Kindler HL
Semin Oncol; 2002 Apr; 29(2 Suppl 5):42-9. PubMed ID: 12023792
[TBL] [Abstract][Full Text] [Related]
10. Pemetrexed in the treatment of non-small cell lung cancer.
Shepherd FA
Semin Oncol; 2002 Dec; 29(6 Suppl 18):43-8. PubMed ID: 12571810
[TBL] [Abstract][Full Text] [Related]
11. Pemetrexed (Alimta, MTA, multitargeted antifolate, LY231514) for malignant pleural mesothelioma.
Manegold C
Semin Oncol; 2003 Aug; 30(4 Suppl 10):32-6. PubMed ID: 12917819
[TBL] [Abstract][Full Text] [Related]
12. Clinical activity of pemetrexed: a multitargeted antifolate anticancer agent.
Solomon B; Bunn PA
Future Oncol; 2005 Dec; 1(6):733-46. PubMed ID: 16556051
[TBL] [Abstract][Full Text] [Related]
13. Phase I trials of pemetrexed.
Fossella FV; Gatzemeier U
Semin Oncol; 2002 Apr; 29(2 Suppl 5):8-16. PubMed ID: 12023787
[TBL] [Abstract][Full Text] [Related]
14. Pemetrexed in the treatment of selected solid tumors.
Adjei AA
Semin Oncol; 2002 Apr; 29(2 Suppl 5):50-3. PubMed ID: 12023793
[TBL] [Abstract][Full Text] [Related]
15. Pemetrexed: a multitargeted antifolate (ALIMTA, LY-231514).
Jones RJ; Twelves CJ
Expert Rev Anticancer Ther; 2002 Feb; 2(1):13-22. PubMed ID: 12113062
[TBL] [Abstract][Full Text] [Related]
16. Pemetrexed: a promising new treatment for breast cancer.
O'Shaughnessy JA; Gennari A; Conte P
Semin Oncol; 2002 Apr; 29(2 Suppl 5):36-41. PubMed ID: 12023791
[TBL] [Abstract][Full Text] [Related]
17. Pemetrexed, an novel multitargeted antifolate: current development and future directions. Proceedings of a meeting. August 17-19, 2000. Colorado Springs, Colorado, USA.
Semin Oncol; 2002 Apr; 29(2 Suppl 5):1-61; quiz 62-9. PubMed ID: 12023785
[No Abstract] [Full Text] [Related]
18. Pemetrexed in gastric cancer: clinical experience and future perspectives.
Celio L; Buzzoni R; Longarini R; Marchianò A; Bajetta E
Semin Oncol; 2002 Dec; 29(6 Suppl 18):63-8. PubMed ID: 12571814
[TBL] [Abstract][Full Text] [Related]
19. Overview of phase I/II pemetrexed studies.
Hanauske AR; Dittrich C; Otero J
Oncology (Williston Park); 2004 Nov; 18(13 Suppl 8):18-25. PubMed ID: 15655932
[TBL] [Abstract][Full Text] [Related]
20. Incorporation of pemetrexed (Alimta) into the treatment of non-small cell lung cancer (thoracic tumors).
Bunn PA
Semin Oncol; 2002 Jun; 29(3 Suppl 9):17-22. PubMed ID: 12094334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]